Daily Endocrinology Research Analysis
Three standout studies span mechanistic endocrinology and data science. A mixed clinical–experimental study shows that TSH directly remodels cardiomyocyte electrophysiology via TSHR/cAMP/PKA, aligning with higher AF prevalence in subclinical hypothyroidism. A PNAS study defines TGFBR2 as a coordinator of estrogen responses in endometrium, impacting hyperplasia and fertility. CelLink introduces a robust single-cell multi-omics integrator that handles weak feature linkage and imbalanced population
Summary
Three standout studies span mechanistic endocrinology and data science. A mixed clinical–experimental study shows that TSH directly remodels cardiomyocyte electrophysiology via TSHR/cAMP/PKA, aligning with higher AF prevalence in subclinical hypothyroidism. A PNAS study defines TGFBR2 as a coordinator of estrogen responses in endometrium, impacting hyperplasia and fertility. CelLink introduces a robust single-cell multi-omics integrator that handles weak feature linkage and imbalanced populations, enabling spatial endocrine biology.
Research Themes
- Thyroid–cardiac axis and arrhythmia risk
- TGFβ signaling in endometrial biology and fertility
- AI-enabled single-cell multi-omics integration for endocrine research
Selected Articles
1. Thyrotropin Directly Affects Cardiac Electrophysiology and Is Associated With AF Prevalence.
In a retrospective cohort of 2,311 subclinical hypothyroidism patients, higher TSH levels correlated with greater AF prevalence. Complementary experiments showed TSH directly modulates cardiomyocyte ion channel expression and electrophysiology via TSHR/cAMP/PKA, increasing automaticity and altering action potentials.
Impact: This work links a common endocrine abnormality to arrhythmia via a direct mechanistic pathway, informing risk assessment beyond thyroid hormone levels alone.
Clinical Implications: Consider heightened AF surveillance in subclinical hypothyroidism, especially with TSH >10 mU/L. While causality needs trials, findings support integrating TSH levels into arrhythmia risk stratification and motivate studies of TSH-lowering strategies on AF outcomes.
Key Findings
- Among 2,311 SH patients, AF prevalence increased with higher TSH (32.1% at 4–10 mU/L vs 44.6% at >10 mU/L).
- TSH altered cardiomyocyte ion channel mRNA/protein expression and increased automaticity in HL-1 and neonatal rat cardiomyocytes.
- Mechanistic pathway implicated TSHR/cAMP/PKA signaling with action potential remodeling confirmed by patch-clamp, optical mapping, and modeling.
Methodological Strengths
- Integrated clinical cohort analysis with multi-modal electrophysiological experiments (patch-clamp, optical mapping) and computational modeling.
- Dose–response exploration linking TSH levels to AF prevalence and cellular phenotypes.
Limitations
- Retrospective design with potential residual confounding in the clinical association.
- Translational gap from in vitro/rodent cardiomyocytes to human myocardial tissue-level effects.
Future Directions: Prospective studies to validate AF risk across TSH strata and interventional trials testing whether TSH lowering modifies AF incidence/recurrence; human tissue studies to map ion channel remodeling under TSH exposure.
BACKGROUND: Although hyperthyroidism is known to increase the risk of atrial fibrillation (AF), subclinical hypothyroidism (SH) is an often-underreported condition characterized by elevated thyroid-stimulating hormone (TSH) levels and normal fT3/fT4 levels. This study aimed to clarify the association between SH and AF and to identify potential direct electrophysiological effects of TSH. METHODS: We retrospectively included 2311 patients diagnosed with SH between 2007 and 2020 who had an ECG within 7 days of diagnosis. Logistic regression analysis identified factors independently associated with AF in patients with SH. Effects of different TSH doses on ion channel mRNA and protein levels were analyzed in HL-1 and neonatal rat cardiomyocytes. Video analysis with MYOCYTER, patch-clamp, optical mapping, and computational modeling were used to study automaticity and action potential characteristics after TSH application. RESULTS: AF was documented more often with higher TSH levels (4-10 mU/L TSH: 32.1% versus >10 mU/L TSH: 44.6%; CONCLUSIONS: Individuals with SH exhibit an increased prevalence of AF, which is likely in part due to a direct effect of TSH on ion channel expression in cardiomyocytes via the TSHR/cAMP/PKA pathway.
2. CelLink: integrating single-cell multi-omics data with weak feature linkage and imbalanced cell populations.
CelLink introduces an optimal-transport–based, multi-phase pipeline that integrates single-cell modalities under weak feature linkage and imbalanced populations, excluding unreliable matches to prevent error propagation. Benchmarks show superior mixing, manifold preservation, and feature imputation, uniquely enabling transcriptome imputation for spatial proteomics to support spatial endocrine biology.
Impact: A generalizable integration method that solves two key pain points in single-cell multi-omics will be foundational across endocrine tissues (islets, thyroid, pituitary) and spatial analyses.
Clinical Implications: While methodological, CelLink enables higher-fidelity cellular maps of endocrine organs, improving target discovery, subtype annotation, and spatial context for disease processes (e.g., islet autoimmunity, thyroid cancer microenvironment).
Key Findings
- Introduces a multi-phase optimal transport pipeline with normalization/smoothing and dynamic exclusion of unmapped cells to handle weak linkage and imbalanced populations.
- Outperforms state-of-the-art methods on data mixing, manifold preservation, and feature imputation across scRNA-seq, spatial proteomics, and CITE-seq benchmarks.
- Enables transcriptomic profile imputation from spatial proteomics, supporting spatial transcriptomic analyses and correction of mislabeled cells.
Methodological Strengths
- Iterative optimal transport with dynamic cell matching and explicit handling of imbalanced populations.
- Extensive benchmarking across multiple modalities and tasks, including spatial proteomics imputation.
Limitations
- Performance may depend on parameter choices and dataset-specific preprocessing.
- Primarily computational validation; limited wet-lab orthogonal validation of imputed features.
Future Directions: Apply CelLink to endocrine organ atlases (islet, thyroid, pituitary) and integrate with perturbational datasets; develop uncertainty quantification for imputations and prospective experimental validation.
Single-cell multi-omics technologies capture complementary molecular layers, enabling a comprehensive view of cellular states and functions. However, integrating these data types poses significant challenges when their features are weakly linked and cell population sizes are imbalanced. Currently, no method efficiently addresses these two issues simultaneously. Therefore, we developed CelLink, a novel single-cell multi-omics data integration method designed to overcome these challenges. CelLink normalizes and smooths feature profiles to align scales across datasets and integrates them through a multi-phase pipeline that iteratively employs the optimal transport algorithm. It dynamically refines cell-cell correspondences, identifying and excluding cells that cannot be reliably matched, thus avoiding performance degradation caused by erroneous imputations. This approach effectively adapts to weak feature linkage and imbalanced cell populations between datasets. Benchmarking CelLink on scRNA-seq and spatial proteomics datasets, as well as paired CITE-seq data, demonstrates its superior performance across various evaluation metrics, including data mixing, cell manifold structure preservation, and feature imputation accuracy. Compared to state-of-the-art methods, CelLink significantly outperforms others in imbalanced cell populations while consistently achieving better performance for balanced datasets. Moreover, CelLink uniquely enables cell subtype annotation, correction of mislabeled cells, and spatial transcriptomic analyses by imputing transcriptomic profiles for spatial proteomics data. Its great ability to impute large-scale paired single-cell multi-omics data positions it pivotal for building single-cell multi-modal foundation models and spatial cellular biology.
3. TGFBR2 coordinates the endometrial response to estrogen, regulating endometrial hyperplasia and fertility.
Using a progesterone receptor–Cre conditional knockout, the authors define TGFBR2 as a coordinator of estrogen responses in endometrium, linking its signaling to regulation of endometrial hyperplasia and fertility. The work delineates receptor-specific roles within TGFβ signaling in uterine biology.
Impact: Receptor-specific dissection of TGFβ signaling in endometrium advances mechanistic understanding of hyperplasia and fertility, opening avenues for targeted modulation.
Clinical Implications: While preclinical, mapping TGFBR2’s role may inform biomarkers and therapeutic strategies for endometrial hyperplasia, infertility, and potentially endometrial cancer prevention.
Key Findings
- Conditional endometrial deletion of TGFBR2 (via progesterone receptor–Cre) reveals TGFBR2 as a key coordinator of estrogen responses.
- TGFBR2 signaling is implicated in regulating endometrial hyperplasia.
- Loss or modulation of TGFBR2 impacts fertility outcomes in the mouse model.
Methodological Strengths
- Tissue-specific conditional knockout enabling receptor-level dissection within TGFβ signaling.
- In vivo model directly linking receptor function to reproductive phenotypes.
Limitations
- Mouse model findings may not fully extrapolate to human endometrium.
- Abstracted details on molecular and phenotypic endpoints are limited in the available text.
Future Directions: Validate TGFBR2-dependent pathways in human endometrial tissue and assess therapeutic modulation in models of hyperplasia and subfertility.
Proper endometrial function is critical for establishing and maintaining healthy pregnancies, as well as preventing the pathogenesis of conditions such as endometrial hyperplasia and endometrial cancer. The TGFβ signaling pathway regulates key aspects of endometrial biology, although the direct effects of many individual receptors remain unstudied. In this study, we characterize the role of TGFβR2 within the endometrium using a progesterone receptor-cre conditional knock-out mouse model (